Human plasma B cells, engineered to produce anti-CD19 bispecific antibodies, used successfully for the first time to treat #leukemia in an #Animal models - Study in @MolTherapy of @CellCellPress https://t.co/bB9vbGifUy https://t.co/rBIgVSpgDG
Engineered plasma B cells for treatment of leukemia show long-lasting activity in humanized mice. Red more in @MolTherapy: https://t.co/VEvF5YSr76 @ScienceRicker https://t.co/aL06N4Cg7D
Researchers have developed engineered human plasma B cells that secrete bispecific antibodies to treat leukemia in mice. This innovative approach shows promise in targeting and eliminating leukemia cells. https://t.co/KWjkf81bU3
RT @CellPressNews: Engineered plasma B cells for treatment of leukemia show long-lasting activity in humanized mice. Red more in @MolThera…